Can B (CANB) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 07, 2025)

View and export this data going back to 2011. Start your Free Trial

What is Can B Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Can B's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Can B's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Can B's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Can B's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Can B's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Can B's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Can B (OTCPK:CANB) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Can B Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Can B's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Can B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Can B Corp (OTCPK:CANB) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

960 South Broadway, Suite 120, Hicksville, NY, USA, 11801

Website

https://www.canbiola.com

Can B Corp is engaged in the business of promoting health and wellness through its development, manufacture and sale of products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. The company focuses on developing a line of proprietary products in the Hemp Industry.

Executives

Mckenzie Webster Ltd	10 percent owner	DMS HOUSE, DR. ROYCE DRIVE, GEORGE TOWN, GRAND CAYMAN E9 KY1-1102
Stanley L Teeple	director, officer: CFO, Director, and Secretary	94 ARTHUR HILL COURT, HENDERSON NV 89014
Andrew Holtmeyer	officer: EVP Business Development	65 LAUREN AVE, SUITE 301, HUNTINGTON STATION NY 11746
Heggenhougen Rolv	director	90 NORTH CHURCH STREET, GEORGETOWN E9 KY1-1102
David J Posel	officer: COO	6103 CARMEL LN SE, LACEY WA 98503
Rolv Heggenhougen	10 percent owner	445 NE 12TH AVENUE, FORT LAUDERDALE FL 33301
Marco Alfonsi	director, 10 percent owner, officer: CEO, Board Member	44 EAST END AVENUE, HICKSVILLE NY 11801
Carl Dilley	director	15500 ROOSEVELT BLVD., SUITE 301, CLEARWATER FL 33760